High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.
about
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinomaAlpha B-crystallin correlates with poor survival in colorectal cancer.New insight into benign tumours of major salivary glands by proteomic approach.Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.Heat shock factor 1 induces crystallin-αB to protect against cisplatin nephrotoxicity.Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic targetRestoring TRAIL mediated signaling in ovarian cancer cells.RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.Chaperones: needed for both the good times and the bad times.Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.Identification of influential observations in high-dimensional cancer survival data through the rank product test.Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer
P2860
Q21261248-1160E128-458F-4149-BD3B-B1B974A31776Q34371573-6B3BAFAC-0A7A-43FE-A913-DD45E31809ECQ35037000-54748EFE-799C-484C-85DA-08EE9A65C5B0Q36112218-B90D4D7B-4E67-45D0-9CD6-7F8EEC34E1A9Q37139438-A1298B14-4F00-49B4-AC7F-85EE0D9D7438Q37223322-B4645B80-3BCC-4BD2-A4DD-EBA9AB539629Q37241367-6DAE7BA3-94F0-4880-97AC-D3E13B254491Q38230205-519346A9-DD73-4A5D-B797-B11332B8CBCCQ38852995-14CFA4F3-7CDD-4D05-9137-DE7CA69EA3C2Q40183775-19CFD134-BE8D-4BE7-84EE-70D093D3399CQ41215316-7F97C65F-BE39-42B1-B910-DFA70A467496Q43699188-BF74955C-3497-4336-BF50-C9B7958F3A8DQ49884507-865BDE3B-C5A2-481D-AB8A-1888AAEB37F1Q52655175-1D270506-9180-4402-A075-94C90838AEAFQ57475208-E091072A-86B7-4F12-9E25-482C51CF3DCF
P2860
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High expression of crystallin ...... in human ovarian cancer cells.
@en
High expression of crystallin ...... in human ovarian cancer cells.
@nl
type
label
High expression of crystallin ...... in human ovarian cancer cells.
@en
High expression of crystallin ...... in human ovarian cancer cells.
@nl
prefLabel
High expression of crystallin ...... in human ovarian cancer cells.
@en
High expression of crystallin ...... in human ovarian cancer cells.
@nl
P2093
P2860
P50
P356
P1476
High expression of crystallin ...... in human ovarian cancer cells
@en
P2093
Aaron Becker V Ros
Barbara Schmalfeldt
Felix Hilpert
Juliane Ramser
Marion Kiechle
Martina Rudelius
Matthias Dürst
Tibor Schuster
Ute Reuning
P2860
P304
P356
10.1002/IJC.27975
P577
2012-12-27T00:00:00Z